Outpatients with symptomatic atherothrombotic vascular disease continue to experience high rates of recurrent vascular events and rehospitalizations at 3 years despite contemporary medical therapy.
No takes yet. Share an insight, caveat, or question.
Symptomatic patients face doubled 3-year vascular event rates despite therapy; supports intensified prevention trials but should not yet change practice.
Alberts et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: